BioProcess Containers
Oxoid Cold filterable Tryptone Soya Broth (cfTSB) and Cold filterable Vegetable Peptone Broth (cfVPB) have been specially developed for media fill trials, and meets the increasing regulatory demands of aseptic process validations.
Oxoid Cold filterable Tryptone Soya Broth (cfTSB) and Cold filterable Vegetable Peptone Broth (cfVPB) have been specially developed for media fill trials, and meets the increasing regulatory demands of aseptic process validations. This product is now available ready made in BioProcess Containers (BCPs) that plug directly into the production line.
BioProcess Containers are engineered specifically for pharmaceutical applications – single-use, flexible, low-density polythene containers. This format takes the headache out of media fill trials by eliminating lengthy media preparation and time-consuming QC. You can quickly complete your regulatory obligations and restart production, knowing that your aseptic processes are robust and validated.
The formulation of Oxoid Cold Filterable TSB medium conforms to that stated for media fill trials in the European, the U.S. and the Japanese Pharmacopoeias. Oxoid Cold filterable Vegetable Peptone Broth (cfVPB) provides an animal-derived component-free alternative.
The WFI quality water meets current USP production and test requirements. BPCs are constructed of superior medical grade plastics that meet USP Class VI requirements.
Oxoid Cold Filterable Tryptone Soya Broth and Cold Filterable Vegetable Peptone Broth are available in 10 and 20-litre BioProcess Containers; other sizes are custom-made.
Find out more here.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
